Chemoenzymatic synthesis of cholesteryl-6-O-tetradecanoyl-α-D-glucopyranoside: a product of host cholesterol efflux promoted by Helicobacter pylori.
Ryan A Davis, Chun-Hung Lin, Jacquelyn Gervay-Hague
Index: Chem. Commun. (Camb.) 48(72) , 9083-5, (2012)
Full Text: HTML
Abstract
In a three-step protocol involving regioselective enzymatic acylation, per-O-trimethylsilylation, and a one-pot α-glycosidation-deprotection sequence, cholesteryl-6-O-tetradecanoyl-α-D-glucopyranoside (α-CAG) of Helicobacter pylori is afforded starting from glucose in an overall yield of 45%. The production of CAG can be scaled to make purified quantities available to the biological community for the first time.
Related Compounds
Related Articles:
2011-05-01
[Biochim. Biophys. Acta 1811 , 314-322, (2011)]
Glucosylsterol and acylglucosylsterol of snake epidermis: structure determination.
1987-04-01
[J. Lipid Res. 28(4) , 446-9, (1987)]
Steryl glycosides: a characteristic feature of the Helicobacter spp.?
1995-09-01
[J. Bacteriol. 177(18) , 5334-7, (1995)]
2010-03-15
[Chemistry 16(11) , 3536-44, (2010)]
Therapeutic potential of cholesteryl O-acyl α-glucoside found in Helicobacter pylori.
2012-01-01
[Curr. Med. Chem. 19(28) , 4869-74, (2012)]